News
StratifyMDX Announces Meraki - The Most Advanced Intelligent Health Agent for Proactive, Personalized Care BOULDER, CO / ACCESS Newswire / August 7, 2025 / StratifyMDX is proud to announce Meraki, a ...
VANCOUVER, WASHINGTON / ACCESS Newswire / August 7, 2025 / Sinceri Senior Living is proud to announce a strategic expansion through the addition of six senior living communities in partnership with ...
Groundbreaking Visual Tool Designed to Help Hygienists Communicate More Clearly and Convert More Treatment LEHI, UTAH / ACCESS Newswire / August 7, 2025 / Alta AI, the leading voice technology ...
New data from Eurofins Discovery show that Telomir-1 blocks enzymes that drive disease by turning off critical genes-highlighting its potential to treat cancer, autoimmune conditions, ...
For the Sixth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC / ACCESS Newswire / August 7, 2025 / Bausch Health Companies Inc. (NYSE:BHC ...
Continued ISO 27001, 27017, 27018, 13485, SOC 2 Type 2, and HITRUST Certification Reflects Ongoing Commitment to Trusted ...
First, data and digital business services company, has been recognised as a Major Contender in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025. This recognition reflects ...
Quarter Results07.08.2025 / 12:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate ...
Conference call on the results for the 3rd quarter 2024/2025 (ending 30 June 2025) on 14 August 2025
Conference/Quarter ResultsConference call on the results for the 3rd quarter 2024/2025 (ending 30 June 2025) on 14 August 2025 07.08.2025 / 12:12 CET/CESTThe issuer is solely responsible for the ...
It's Rotten Weed."This is the height of hypocrisy," said Duane Boise, CEO MMJ. "DEA bureaucrats are blocking clean cannabis grown in a DEA inspected cultivation facility, while contaminated products ...
Global Brachytherapy Market to Grow at 7% CAGR Driven by Cancer Burden and Tech Advancements by 2030
The global brachytherapy market is set to witness a growth rate of ~7% in the next 5 years. Rising global cancer burden, ...
Global Cell and Gene Therapy Market to Grow at 23% CAGR Driven by R&D and Regulatory Support by 2030
The global cell and gene therapy market is experiencing significant expansion, driven by rising approvals and advancements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback